Page 8 - Linical Evolution News Today

A breast cancer drug that has been used for many years to treat the disease, has been licensed today (November 7) as a preventative measure.

People with Alcohol Use Disorder (AUD) could benefit from taking a daily tablet that could see their intake reduced by half in just three months.

Medidata has recommitted to Catalyst Clinical Research to support its worldwide oncology brand, Catalyst Oncology.

Enzyme replacement therapy (ERT) made its debut in 1991, heralding a breakthrough in medical science for individuals and families grappling with rare diseases stemming from single gene mutations.

Unfortunately, more than 700 rare diseases affect more than 30 million people in the US alone and with many of them being life threatening, it is still a concern that most still do not have treatments.

Integrated drug discovery contract research organization (CRO) Sygnature Discovery has invested £3.75 million in an Azenta compound management storage system that can also provide customer libraries.

The Gen AI revolution promises to redefine various industries, with the life sciences sector at the forefront of this transformation. OSP had the chance to speak to Tarun Mathur, CEO at Indegene, who was keen to allay many of the fears those in the industry may have.

Contract research organization (CRO), Phastar, has had its net-zero target approved by SBTi which it hopes to achieve by adopting stringent sustainability standards.

Biotech company, AstronauTx Ltd today (October 9) announced the completion of a £48 million ($61 million) Series A financing.

At DPharm 2023, there was a huge meeting of minds to discuss the latest innovations in clinical trials. Outsourcing Pharma was delighted to have an in-depth discussion with IQVIA’s Elan Josielewski, senior principal and head of operations, patient centred solutions and Anthony Mikulaschek, vice president of electronical clinical outcomes assessment (eCOA).